|
FOXRED2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.97949998007141E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62458935193399E-12 |
| Normal-vs-Stage2 |
8.632800E-04 |
| Normal-vs-Stage3 |
3.734100E-02 |
| Normal-vs-Stage4 |
1.60702999999485E-05 |
| Stage1-vs-Stage2 |
3.268200E-01 |
| Stage1-vs-Stage3 |
4.558300E-02 |
| Stage1-vs-Stage4 |
4.630200E-01 |
| Stage2-vs-Stage3 |
4.210600E-01 |
| Stage2-vs-Stage4 |
2.942800E-01 |
| Stage3-vs-Stage4 |
4.557900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.85879997452554E-09 |
| Normal-vs-AfricanAmerican |
2.38697950294409E-14 |
| Normal-vs-Asian |
8.924900E-03 |
| Caucasian-vs-AfricanAmerican |
1.664170E-03 |
| Caucasian-vs-Asian |
9.801800E-01 |
| AfricanAmerican-vs-Asian |
2.675200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.92449977965259E-10 |
| Normal-vs-Female |
6.71480000491442E-08 |
| Male-vs-Female |
7.427200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.73889999861055E-08 |
| Normal-vs-Extreme_Weight |
2.09976480647356E-12 |
| Normal-vs-Obese |
1.53845999999458E-05 |
| Normal-vs-Extreme_Obese |
1.75349999964602E-07 |
| Normal_Weight-vs-Extreme_Weight |
4.092600E-01 |
| Normal_Weight-vs-Obese |
3.944000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.830400E-01 |
| Extreme_Weight-vs-Obese |
9.060300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.185200E-01 |
| Obese-vs-Extreme_Obese |
3.094400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.398200E-02 |
| Normal-vs-Age(41-60Yrs) |
8.81719997014585E-09 |
| Normal-vs-Age(61-80Yrs) |
3.73030051292744E-10 |
| Normal-vs-Age(81-100Yrs) |
2.24229999999936E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.040630E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.659900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.443000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.531000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.353200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.700200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.80189196896663E-12 |
| Normal-VS-Type2 PRCC |
1.622390E-04 |
| Normal-VS-KIRP CIMP |
6.486400E-02 |
| Normal-VS-Unclassified PRCC |
4.31219999996735E-06 |
| Type1 PRCC-VS-Type2 PRCC |
3.040000E-02 |
| Type1 PRCC-VS-KIRP CIMP |
6.923800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.744100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
7.353800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.967200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.225000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.818300E-03 |
| Normal-vs-N1 |
4.390100E-02 |
| Normal-vs-N2 |
7.418500E-03 |
| N0-vs-N1 |
8.001400E-01 |
| N0-vs-N2 |
4.819800E-01 |
| N1-vs-N2 |
4.227200E-01 |
|
|
